In Vitro Evaluation of Marketed Tablets for Urolithiasis Treatment

Urolithiasis, characterized by the formation of calculi in the urinary tract, poses significant clinical challenges. This review examines the in vitro efficacy of marketed tablets designed for its management, focusing on their pharmacological properties, dissolution profiles, and active ingredients.Urolithiasis, a prevalent condition marked by stone formation in the urinary tract, requires effective management strategies. This review focuses on the in vitro evaluation of marketed tablets, assessing their pharmacological effectiveness, dissolution characteristics, and active ingredients.Urolithiasis, a common urinary disorder characterized by the formation of calculi, necessitates effective pharmacological management. This review evaluates the in vitro performance of marketed tablets designed for the treatment of urolithiasis, including potassium citrate, allopurinol, and herbal formulations. Key focus areas include the dissolution profiles, crystallization inhibition capabilities, and active ingredient efficacy of these products. In vitro studies indicate that potassium citrate and allopurinol significantly enhance stone dissolution and prevent crystallization, while the effectiveness of herbal formulations remains variable and requires further investigation. Understanding these in vitro characteristics is crucial for optimizing therapeutic strategies and improving patient outcomes in urolithiasis management.